Omnicell (OMCL) Short Interest Ratio & Short Volume → Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad) Free OMCL Stock Alerts $29.29 +2.12 (+7.80%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Omnicell Short Interest DataCurrent Short Volume2,370,000 sharesPrevious Short Volume2,320,000 sharesChange Vs. Previous Month+2.16%Dollar Volume Sold Short$63.71 millionShort Interest Ratio / Days to Cover4.2Last Record DateApril 15, 2024Outstanding Shares45,920,000 sharesPercentage of Shares Shorted5.16%Today's Trading Volume604,883 sharesAverage Trading Volume536,559 sharesToday's Volume Vs. Average113% Short Selling Omnicell ? Sign up to receive the latest short interest report for Omnicell and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOMCL Short Interest Over TimeOMCL Days to Cover Over TimeOMCL Percentage of Float Shorted Over Time Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... Omnicell Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,370,000 shares $63.71 million +2.2%N/A4.2 $26.88 3/31/20242,320,000 shares $67.81 million +1.3%N/A4.1 $29.23 3/15/20242,290,000 shares $63.41 million +0.4%N/A4.1 $27.69 2/29/20242,280,000 shares $59.83 million +5.1%N/A3.7 $26.24 2/15/20242,170,000 shares $61.41 million +8.0%N/A3.5 $28.30 1/31/20242,010,000 shares $64.66 million -4.7%N/A3.3 $32.17 Get the Latest News and Ratings for OMCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Omnicell and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,110,000 shares $72.10 million -6.2%5.8%3.3 $34.17 12/31/20232,250,000 shares $84.67 million -2.6%N/A3.4 $37.63 12/15/20232,310,000 shares $88.38 million +9.5%N/A3.4 $38.26 11/30/20232,110,000 shares $70.39 million -16.3%N/A2.7 $33.36 11/15/20232,520,000 shares $84.22 million No ChangeN/A3.3 $33.42 10/31/20232,520,000 shares $89.56 million -7.4%N/A3.5 $35.54 10/15/20232,720,000 shares $114.62 million -9.0%N/A4.2 $42.14 9/30/20232,990,000 shares $134.67 million +25.1%N/A4.7 $45.04 9/15/20232,390,000 shares $132.76 million +8.6%N/A4 $55.55 8/31/20232,200,000 shares $125.09 million -0.9%N/A5 $56.86 8/15/20232,220,000 shares $143.59 million -10.5%N/A5.5 $64.68 7/31/20232,480,000 shares $156.61 million -11.4%N/A5.9 $63.15 7/15/20232,800,000 shares $202.64 million +1.5%N/A6.9 $72.37 6/30/20232,760,000 shares $203.33 million -9.2%N/A7.3 $73.67 6/15/20233,040,000 shares $219.85 million -5.0%N/A7.7 $72.32 5/31/20233,200,000 shares $234.94 million +11.1%N/A7.7 $73.42 5/15/20232,880,000 shares $201.69 million +1.8%N/A6.4 $70.03 4/30/20232,830,000 shares $171.98 million -5.0%N/A6.3 $60.77 4/15/20232,980,000 shares $177.91 million +4.2%N/A6.7 $59.70 3/31/20232,860,000 shares $167.80 million +4.0%N/A6.2 $58.67 3/15/20232,750,000 shares $151.97 million +4.2%N/A5.7 $55.26 2/28/20232,640,000 shares $143.72 million -4.7%N/A4.9 $54.44 2/15/20232,770,000 shares $153.04 million -12.6%N/A5.2 $55.25 1/31/20233,170,000 shares $175.84 million -4.5%N/A5.3 $55.47 1/15/20233,320,000 shares $189.44 million -3.2%N/A4.7 $57.06 12/30/20223,430,000 shares $172.94 million +12.8%N/A4.8 $50.42 12/15/20223,040,000 shares $147.26 million +3.8%N/A4.4 $48.44 11/30/20222,930,000 shares $151.22 million -7.9%N/A4.4 $51.61 11/15/20223,180,000 shares $177.60 million -3.1%N/A5.4 $55.85 10/31/20223,280,000 shares $253.61 million -3.5%N/A6 $77.32 10/15/20223,400,000 shares $249.08 million +18.5%N/A8.5 $73.26 9/30/20222,870,000 shares $249.78 million -4.0%N/A7.5 $87.03 9/15/20222,990,000 shares $286.32 million -1.0%N/A5.2 $95.76 8/31/20223,020,000 shares $308.92 million -2.9%N/A5.4 $102.29Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here OMCL Short Interest - Frequently Asked Questions What is Omnicell's current short interest? Short interest is the volume of Omnicell shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 2,370,000 shares of OMCL short. Learn More on Omnicell's current short interest. What is a good short interest ratio for Omnicell? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMCL shares currently have a short interest ratio of 4.0. Learn More on Omnicell's short interest ratio. Which institutional investors are shorting Omnicell? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Omnicell: Concourse Financial Group Securities Inc., Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Omnicell's short interest increasing or decreasing? Omnicell saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,370,000 shares, an increase of 2.2% from the previous total of 2,320,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Omnicell's short interest compare to its competitors? Here is how the short interest of companies compare to Omnicell: Ligand Pharmaceuticals Incorporated (4.98%), 4D Molecular Therapeutics, Inc. (19.21%), Pacira BioSciences, Inc. (7.42%), Verona Pharma plc (7.51%), Ironwood Pharmaceuticals, Inc. (13.96%), Collegium Pharmaceutical, Inc. (22.86%), Spyre Therapeutics, Inc. (10.55%), Belite Bio, Inc (0.12%), Mirum Pharmaceuticals, Inc. (18.21%), Brookdale Senior Living Inc. (11.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Omnicell stock? Short selling OMCL is an investing strategy that aims to generate trading profit from Omnicell as its price is falling. OMCL shares are trading up $2.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Omnicell? A short squeeze for Omnicell occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OMCL, which in turn drives the price of the stock up even further. How often is Omnicell's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMCL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Ligand Pharmaceuticals Short Interest Data 4D Molecular Therapeutics Short Interest Data Pacira BioSciences Short Interest Data Verona Pharma Short Interest Data Ironwood Pharmaceuticals Short Interest Data Collegium Pharmaceutical Short Interest Data Spyre Therapeutics Short Interest Data Belite Bio Short Interest Data Mirum Pharmaceuticals Short Interest Data Brookdale Senior Living Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OMCL) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsThe A.I. story nobody is telling you (Read ASAP)TradeSmithAI “wealth window” is closing June 25thParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders